At the G20 Global Health Summit in Italy today, world leaders and drug companies announced major commitments to boost the supply of COVID vaccine for low- and middle-income countries, but stopped short of endorsing a full waiver of vaccine patent rights.So far, about 1.59 billion vaccine doses have been given worldwide, about 84% of it deployed in higher-income countries, according to the New York Times.
The summit today, hosted by the European Commission and Italy, comes as the vaccine gap becomes more acute, with supplies expected from India delayed due to the country's catastrophic surge.Countries agree on principles for ending pandemicAt today's summit, the G20 countries agreed on common principles for ending the pandemic, with the